Sorry, you need to enable JavaScript to visit this website.

Title: Section 12.3 - Precautions to be observed for the prevention of hemorrhagic diseases and coagulation disorders of the newborn and infants related to vitamin K deficiency

Effective Date

06/10/2014

12.3 Precautions to be observed for the prevention of hemorrhagic diseases and coagulation disorders of the newborn and infants related to vitamin K deficiency. It shall be the duty of the attending physician, licensed midwife, registered professional nurse or other licensed medical professional attending the newborn to assure administration of a single intramuscular dose of 0.5 - 1.0 mg. of vitamin K1 oxide (phytonadione) within six hours of birth in accordance with current standards of medical care.

Volume

VOLUME A (Title 10)

up